medigraphic.com

2000, Número 6

<< Anterior Siguiente >>

Arch Cardiol Mex 2000; 70 (6)


Efecto de la rehabilitación cardiaca en pacientes isquémicos no sometidos a revascularización coronaria

Leyva GMA, Ramírez ROHA

Idioma: Español
Referencias bibliográficas: 35
Paginas: 552-560
Archivo PDF: 149.76 Kb.


RESUMEN

Se realizó un programa de rehabilitación cardiaca (RC) en 65 pacientes con cardiopatía isquémica (CI), rechazados para tratamiento de derivación arterial coronaria (DAC) y angioplastia coronaria transluminal percutánea (ACTP) con seguimiento de 16 ± 2 meses. Se trata de 63 varones (96.9%) y 2 mujeres (3.0%) con edad promedio de 54.5 ± 8.7 años. Los factores de riesgo (FR) son: tabaquismo en 25 pacientes (38.4%), hipercolesterolemia en 47 (72.3%), hipertensión arterial en 33 (50.7%), diabetes mellitus en 30 (46.1%), infarto del miocardio en 56 (86.1%), lesiones coronarias de 1 vaso en 16 (25.5%), de 2 vasos en 25 (38.3%) y de 3 vasos en 24 (36.1%), fracción de expulsión (FE) ‹ 50% en 26 pacientes (40%). Se evaluaron número de vasos lesionados, FE y edad. Un paciente falleció, 52 permanecieron asintomáticos (80%), 10 presentaban angina estable (15.3%) y 3 angina inestable (4.6%). El tabaquismo disminuyó un 92%, la hipertensión se controló en 42.2%, la hipercolesterolemia en 82.9% p ‹ 0.05, la hipertrigliceridemia en 53% p ‹ 0.05, el consumo de O2 (VO2) y el pulso de O2 (PO2) mejoraron en el 64.6% de los pacientes, p = .001 y .01 respectivamente. La RC es una buena alternativa para mejorar la calidad de vida de pacientes fuera de la posibilidad de revascularización coronaria.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Anderson KM, Castelli WP, Levy D: Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 1987; 257: 2176-80.

  2. Gofman JW, Young W, Tandy R: Ischemic heart disease, atherosclerosis and longevity. Circulation 1966; 34: 679-690.

  3. Selwyn AP, Ganz P: The effect of cholesterol lowering and antioxidant the therapy on endothelium dependent coronary vasomotion. N Engl J Med 1995; 332: 488-493.

  4. Lipid Rescarch Clinic Program: The lipid research clinic coronary primary prevention trial result II. The relationship up reduction incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-374.

  5. Buchwald H, Varco RL, Matts JP, Jhon ML, Fitch LL, Campbell GS et al: Effect of partial ileal bypass surgery on mortality and morbity from coronary heart disease in pat ents with hipercholesterolemia. Report of the Program on the surgical Control of the Hyperlipidemia (POSCH). N Engl J Med 1990; 323: 946-955.

  6. Lipid Research Program: The Lipid Research Clinic Coronary Primary. Prevention Trial results I Reduction in the incidence of coronary heart disease. JAMA 1984; 251: 351-354.

  7. Lipid Reseach Program: The Lipid Research Clinics Coronary Primary Prevention Trial result II. The relations-chip of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-374.

  8. The Secandinavian Simvastatin Survival Study Group. Randomised trial of cholestesterol lowering in 4444 patients with coronary heart disease the Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383-1389.

  9. Ost RC, Stenson S: Regresion of peripheral ateroesclerosis during therapy with high doses of nicotinic acid. Scand J Clin Lab Invest 1967; 99: 241-245.

  10. Vos J, de Feyter PJ, Simoons ML, Tijssen JG, Deckers JW: Retardation and arrest of progression or regression of coronary artery disease: A review. Prog Cardiovas Dis 1993; 35: 435-454.

  11. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial: Lancet 1990; 336: 129-133.

  12. Ornish D, Scherwltz LW, Billings JH, Gould KL, Merritt TA, Sparler S et al: Intensive Lifestyle Changes for reversal of Coronary Heart Disease. JAMA 1998; 280: 2001-2007.

  13. Shuler G, Hambrecht R, Shilerf G, Niebauer J, Hauer K, Neumann J, et al: Regular Physical exercise and low fat diet: Effects on progresion of coronary artery disease. Circulation 1992; 86: 1-11.

  14. Levi D, Kannel WB: Cardiovascular risks: new insights from Framingham. Am Heart J 1988; 116: 266-272.

  15. Austin MA: Epidemiologic associations between hypertriglyceridemia and coronary heart disease. Semin Thromb Hemost 1988; 14: 187-142.

  16. Guillman MW, Kannel WB, Belager A, D’agostino R: Influence of heart rate on mortality among persons with hypertension: The Framingham study. Am Heart J 1993; 125: 1148-1154.

  17. Kannel WB, Cobb J: Left ventricular hypertrophy and mortality-results from the Framingham study. Cardiology 1992; 81: 291-298.

  18. Weber KT, Sun Y: Guarda E: Structural remodeling in hypertensive, heart disease and the role of hormona. Hypertension 1994; 23: 869-877.

  19. Hypertension detection and Follow-up Program Cooperative Group: Five years findings of hypertension detection and follow up program. JAMA 1979; 242: 2652-2671.

  20. Hansson L, Zanchetti A, Carruthers S, Dahlöf B, Elmfeld D, Julius S, et al: Efecto del tratamiento hipotensor intensivo aunado a dosis bajas de aspirina en pacientes hipertensos: Principales resultados del estudio aleatorizado sobre tratamiento óptimo de la hipertensión (HOT). Lancet 1998; 351: 1755-1963.

  21. Zanettini R, Bettega D, Agostoni O, Ballestra B, del Rosso G, Michele R, et al: Ejercise training in mild hypertension effect on blood presure, left ventricular mass and coagulation factor VII and fibrinogen. Cardiology 1997; 88(5): 468-473.

  22. Hopkings P, Williams R: A survey of 246 sugested coronary risks factors. Atheroesclerosys 1981; 40: 1-52.

  23. Doll R, Peto R, Whealtley K, Gray R, Sutherland I: Mortality in relation to smoking: 40 years observations on male British doctors. Br Med J 1994; 309: 901-911.

  24. Kawachi I, Colditz GA, Stampfer MJ, Willett W, Manson J, Rosner B: Smoking cessation in relation to total mortality rates in women: A prospective cohort study. Ann Intern Med 1993; 119: 992-1000.

  25. Jonas MA, Oates JA, ckene JK: Hennekens CH: Statement on smokin and cardiovascular disease for healt care professionals: AHA Medical Scientific Statement. Circulation 1992; 86: 1664-1669.

  26. Galan KM, Deligonul U, Kem MJ, Chaitman BR, Vandormael MG: Increased frequency of restenosis in patients continuing to somoke cigarettes afther percutaneous transluminal coronary angioplasty. Am J Cardiol 1988; 61: 260-263.

  27. Alberg A, Bergsrand R: Cessation of smoking after myocardial infarction; effects on mortality after 10 years. Br Heart J 1983; 49: 416-422.

  28. Salone JT: Stopping smoking and long-term mortalily after acute myocardial infarction. Br Heart J 1980; 43: 463-469.

  29. Suarez L, Barret CE: Interact between cigarett smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 1984; 120: 670-675.

  30. Dafoe W, Huston P: Current trends in cardiac rehabilitation. Can Med Assoc l997; 156: 527-532.

  31. Kavanagh T, Myers MG, Baigrie RS, Mertens DJ, Sawyer P, Shephard RJ: Quality of life and cardiorespiratory function in chronic heart failure. Heart 1996; 76: 42-49.

  32. Beniamin Y, Rubenstein JJ, Zaichkowky LD. Effects of hig intensity strongth training on quality of life parameters in cardiac rehabilitation patients. Am J Cardiol 1997; 80: 841-847.

  33. Digenio AG, Noakest TD, Cantor A, Groenveld H, Daly L, Mavunda D, et al. Predictors of exercise capacity and adaptability to training in patients with coronary artery disease. J Cardiopulm Rehabil 1997; 17: 110-120.

  34. Dubach P, Myers J, Dziekan G, Goebbels U, Reinhart W, Vogt P, et al: Effect of exercise on myocardial remodeling in patients with reduced left ventricular function after myocardial infarction: application of magnetic resonance imaging. Circulation 1997; 95: 2060-2067.

  35. Lavie CJ, Milani RV: Effects of cardiac rehabilitation, exercise training; and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 1997; 79: 397-401.




2020     |     www.medigraphic.com